Boston Scientific Corporation (LON:0HOY)
Market Cap | 121.98B |
Revenue (ttm) | 13.38B |
Net Income (ttm) | 1.48B |
Shares Out | n/a |
EPS (ttm) | 1.00 |
PE Ratio | 82.41 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 5,535 |
Average Volume | 43,039 |
Open | 105.91 |
Previous Close | 105.05 |
Day's Range | 104.30 - 105.91 |
52-Week Range | 47.37 - 105.50 |
Beta | 0.81 |
RSI | 62.73 |
Earnings Date | Jan 31, 2025 |
About Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, c... [Read more]
Financial Performance
In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.
Financial numbers in USD Financial StatementsNews

Boston Scientific announces pricing of €1.5 billion of senior notes
MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock
Making a noteworthy insider sell on February 13, EDWARD LUDWIG , Director at Boston Scientific (NYSE: BSX), is reported in the latest SEC filing. What Happened: After conducting a thorough analysis, ...
Boston Scientific Corporation (BSX) Announces Board Member Departure
Boston Scientific Corporation (BSX) Announces Board Member Departure

What's Behind The 130% Rise In BSX Stock?
Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest sto...
Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX)
Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX)
Boston Scientific targets 12%-14% EPS growth for 2025 with strong FARAPULSE and WATCHMAN momentum
Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript
Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsJonathan Monson - SVP, IRMichael...
Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength
Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.

Boston Scientific Clocks 22% Jump In Q4 Sales On Strong Heart Devices, Profit And Guidance Exceeds Expectations
On Wednesday, Boston Scientific Corporation (NYSE: BSX) reported fourth-quarter revenues of $4.56 billion, beating the consensus estimate of $4.424 billion . Sales increased 22.4% on a reported basis...

Boston Scientific sees higher-than-expected 2025 profit on strong demand
Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.
Boston Scientific Corp (BSX) Q4 2024 Earnings: Revenue Surpasses Estimates at $4. ...
Boston Scientific Corp (BSX) Q4 2024 Earnings: Revenue Surpasses Estimates at $4.561 Billion, Adjusted EPS Beats at $0.70

Boston Scientific announces results for fourth quarter and full year 2024
MARLBOROUGH, Mass. , Feb. 5, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024, growing 22.4 percent on a reported ...

Earnings Scheduled For February 5, 2025
Companies Reporting Before The Bell • Aurora Cannabis (NASDAQ: ACB) is likely to report quarterly loss at $0.03 per share on revenue of $80.01 million. • LiveWire Gr (NYSE: LVWR) is estimated to rep...
Boston Scientific Q4 2024 Earnings Preview

$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today
Boston Scientific (NYSE: BSX) has outperformed the market over the past 5 years by 6.26% on an annualized basis producing an average annual return of 19.09%. Currently, Boston Scientific has a market...

Top 4 Health Care Stocks You May Want To Dump In Q1
As of Jan. 21, 2025, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement
Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation
First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Abl...

Boston Scientific Jumps Ahead of Earnings
Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.
Boston Scientific Standing Apart As A Rare Med-Tech Growth Story

We have the largest venture portfolio in medtech, says Boston Scientific CEO Mike Mahoney
Boston Scientific Chair and CEO Mike Mahoney joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare COnference to talk its outlook for 2025, its venture portfolio, and more.
Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific
The Investment Committee discuss some stocks on the move today.

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific
The Investment Committee discuss some stocks on the move today.